12.43
7.94%
-1.05
Novavax, Inc. (NVAX) 最新ニュース
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
The Motley Fool
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool
Zacks Investment Ideas feature highlights: GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia
Zacks Investment Research
New Hotter Inflation Data – Momo Buys The Dip, Fed Blunder Shows Up In Roaring Meme Stocks
Benzinga
Zacks Investment Ideas feature highlights: GameStop, AMC, Novavax, Reddit and Tesla
Zacks Investment Research
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
The Motley Fool
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks Investment Research
Meme Mania is Back: Buy these 3 Stocks
Zacks Investment Research
Company News For May 13, 2024
Zacks Investment Research
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)
Benzinga
Why Novavax Stock More Than Doubled Today
The Motley Fool
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
Benzinga
US Stocks Set To End Week Strong With S&P 500 Eyeing Break Above Late-March Peak: Analyst Says He's Still A Buy In May Amid This Positive Signal
Benzinga
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts
The Motley Fool
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks Investment Research
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks Investment Research
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
The Motley Fool
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks Investment Research
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Zacks Investment Research
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
The Motley Fool
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks Investment Research
Better Buy: Bluebird Bio Vs. Novavax
The Motley Fool
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
Zacks Investment Research
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
The Motley Fool
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment Research
1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague
The Motley Fool
Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
Zacks Investment Research
1 Beaten-Down Stock That's Still Not Worth Buying
The Motley Fool
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
The Motley Fool
Is Novavax a Buy Now?
The Motley Fool
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
The Motley Fool
Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks
Zacks Investment Research
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Novavax (NVAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
Has Novavax Just Solved Its Biggest Problem?
The Motley Fool
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Zacks Investment Research
Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?
Zacks Investment Research
Identifying Trends With Penny Stocks; How to Guide
PennyStocks
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
Benzinga
Better Bull Market Buy: Novavax vs. Pfizer
The Motley Fool
Novavax (NVAX) Q4 Earnings Preview: What's in the Cards?
Zacks Investment Research
Where Will Novavax Be in 10 Years?
The Motley Fool
3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market
The Motley Fool
Better Recovery Story Buy: Novavax vs. Teladoc
The Motley Fool
大文字化:
|
ボリューム (24 時間):